Shree Ganesh Biotech (India) Ltd — Important, 06-04-2026: Company Update

*Please provide the document containing the company’s announcement or update.*

As no document was provided (PFA), I cannot generate a summary based on actual content. However, I can demonstrate how I would apply all your preferences to a *hypothetical* announcement.

**Hypothetical Original Announcement Content (for demonstration purposes):**

"NOTICE is hereby given that a meeting of the Board of Directors of TechInnovate Ltd will be held on Tuesday, November 14, 2023, to consider and approve the standalone unaudited financial results for the quarter and half-year ending September 30, 2023, as required by Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The Board will also evaluate a strategic proposal to acquire a new software division for a consideration of 750 million Indian Rupees, expected to enhance revenue by 20% in the next fiscal year. Furthermore, the appointment of Ms. Jane Smith as an Additional Director will be considered. This announcement is made on November 7, 2023. Any new shares issued will rank pari-passu with existing shares."

---

**Applying your preferences, here is the summary I would generate:**

TechInnovate Ltd has announced a board meeting on Tuesday, November 14, 2023, to consider and approve the financial results for the quarter and half-year. The board will also evaluate a strategic proposal to acquire a new software division for 75 Crore Indian Rupees. This acquisition is anticipated to boost revenue by 20% in the upcoming fiscal year. Additionally, the appointment of Ms. Jane Smith as an Additional Director will be considered. This meeting is pivotal for shareholders, covering both recent financial performance and significant strategic growth initiatives.